Regenerative medicine is a highly promising branch of pharmacology. With the growing demand for stem cell therapies, the need for streamlined manufacturing is more critical than ever. We sat down with senior representatives from Procella Therapeutics, the University of Reading, and Newcastle University to learn more about the future of stem cell production.

Dr Darius Widera shows us three case studies on 3D stem cell cultivation using fibrin, nanofibrillar cellulose, and hybrid scaffolds

David Schaffer, Director, Berkeley Stem Cell Center, University of California, Berkley

Dr. Vasiliki Kalodimou, Director at Flow Cytometry-Research & Regenerative Medicine Department, IASO Maternity & Research Hospital

Vasiliki Kalodimou, Lab Director at the Flow Cytometry-Research and Regenerative Medicine Department of IASO Maternity-Pediatric and Research Hospital

Vivian Li, Group Leader, The Francis Crick Institute

Alfonso Martinez Arias, Professor of Developmental Mechanics, University of Cambridge, UK